$NXGL

Levy Adam R. sold $7K of NXGL

Levy Adam R. (Chief Executive Officer) sold 11,000 shares of NEXGEL, INC. (NXGL) at an average of $0.59 ($0.59–$0.59) across 2 trades over 2026-06-18 to 2026-06-23.

Original reporting
SEC EDGAR · Levy Adam R.
Published Jun 23, 2026, 11:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 23, 2026, 11:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NXGL
Neutral
medium confidence
Mentioned
$NXGL
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NXGLNeutralLow
01

Why it matters

The newest fact is the CEO’s open-market sale of 11,000 shares at ~$0.5926/share, with holdings after the sale of 322,692 shares and no stated 10b5-1 plan.

02

Market read

Provides a fresh datapoint on insider selling activity, which can marginally influence sentiment but does not change fundamentals in the text.

03

What to watch

Check for additional insider transactions around the same dates and whether volume/price action in NXGL coincides with the filing window.

Relevance 3/10Novelty 5/10Timing: filed after-hours on 2026-06-23 (SEC EDGAR Form 4)

Background

The article is an SEC Form 4 insider transaction disclosure for NEXGEL, INC. (NXGL).

Company-level read

Ticker impact

$NXGLNeutralMedium confidence
Context

SEC Form 4 shows CEO Levy Adam R. sold 11,000 NXGL shares in open-market transactions at ~$0.5926/share (filed 2026-06-23).

Expected impact

Low likelihood of sustained price impact; any reaction is likely short-lived unless follow-on selling accelerates.

Evidence & confidence

The filing is a primary-source insider transaction, but it does not include new company performance, guidance, or material corporate event.

Market effects

None indicated; this is company-specific insider dealing.

None indicated.

None indicated.

Counterpoint

Insider sales can be tax- or liquidity-driven; without a 10b5-1 plan, the sale could still be non-informational.

Key entities

  • NEXGEL, INC.

    Subject of the Form 4 insider transaction; CEO sold shares in open-market trades.

  • Levy Adam R.

    CEO and officer/director who sold 11,000 shares between 2026-06-18 and 2026-06-23.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NXGLLow

NEXGEL, INC. (NXGL): Results of Operations and Financial Condition

NEXGEL, INC. (NXGL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEXGEL Reports Second Quarter 2026 Financial Results LANGHORNE, Pa. – August 17, 2026 – NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content